Prudential Financial’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.73M | Sell |
331,168
-180,789
| -35% | -$2.48M | 0.01% | 929 |
|
|
2026
Q1 | $6.36M | Buy |
511,957
+105,817
| +26% | +$1.42M | 0.01% | 814 |
|
|
2025
Q4 | $5.12M | Sell |
406,140
-740,821
| -65% | -$8.48M | 0.01% | 903 |
|
|
2025
Q3 | $11.5M | Sell |
1,146,961
-163,730
| -12% | -$1.47M | 0.01% | 607 |
|
|
2025
Q2 | $10.6M | Sell |
1,310,691
-65,965
| -5% | -$497K | 0.01% | 623 |
|
|
2025
Q1 | $11.5M | Buy |
1,376,656
+192,875
| +16% | +$1.61M | 0.02% | 542 |
|
|
2024
Q4 | $9.38M | Buy |
1,183,781
+270,200
| +30% | +$2.27M | 0.01% | 636 |
|
|
2024
Q3 | $7.6M | Buy |
913,581
+6,210
| +0.7% | +$48.6K | 0.01% | 796 |
|
|
2024
Q2 | $5.76M | Buy |
907,371
+2,175
| +0.2% | +$13.8K | 0.01% | 867 |
|
|
2024
Q1 | $5.49M | Sell |
905,196
-123,130
| -12% | -$694K | 0.01% | 888 |
|
|
2023
Q4 | $6.24M | Sell |
1,028,326
-254,100
| -20% | -$1.13M | 0.01% | 838 |
|
|
2023
Q3 | $5.41M | Sell |
1,282,426
-179,100
| -12% | -$668K | 0.01% | 859 |
|
|
2023
Q2 | $4.53M | Buy |
1,461,526
+264,560
| +22% | +$564K | 0.01% | 938 |
|
|
2023
Q1 | $1.66M | Buy |
1,196,966
+275,250
| +30% | +$548K | ﹤0.01% | 1451 |
|
|
2022
Q4 | $1.83M | Buy |
921,716
+120,250
| +15% | +$270K | ﹤0.01% | 1362 |
|
|
2022
Q3 | $1.62M | Buy |
801,466
+467,300
| +140% | +$1.31M | ﹤0.01% | 1463 |
|
|
2022
Q2 | $1.06M | Sell |
334,166
-28,700
| -8% | -$104K | ﹤0.01% | 1753 |
|
|
2022
Q1 | $1.51M | Sell |
362,866
-106,560
| -23% | -$472K | ﹤0.01% | 1678 |
|
|
2021
Q4 | $2.25M | Sell |
469,426
-367,233
| -44% | -$1.83M | ﹤0.01% | 1475 |
|
|
2021
Q3 | $4.47M | Sell |
836,659
-247,093
| -23% | -$1.24M | 0.01% | 1041 |
|
|
2021
Q2 | $5.55M | Sell |
1,083,752
-215,362
| -17% | -$1.22M | 0.01% | 981 |
|
|
2021
Q1 | $8.74M | Sell |
1,299,114
-73,949
| -5% | -$410K | 0.01% | 818 |
|
|
2020
Q4 | $6.28M | Sell |
1,373,063
-800
| -0.1% | -$3.54K | 0.01% | 918 |
|
|
2020
Q3 | $5.33M | Buy |
1,373,863
+168,629
| +14% | +$721K | 0.01% | 907 |
|
|
2020
Q2 | $5.74M | Buy |
1,205,234
+229,115
| +23% | +$943K | 0.01% | 908 |
|
|
2020
Q1 | $3.4M | Buy |
976,119
+60,239
| +7% | +$255K | 0.01% | 1089 |
|
|
2019
Q4 | $4.41M | Sell |
915,880
-4,708
| -0.5% | -$16.4K | 0.01% | 1189 |
|
|
2019
Q3 | $2.67M | Buy |
920,588
+904,563
| +5,645% | +$3.16M | ﹤0.01% | 1434 |
|
|
2019
Q2 | $115K | Sell |
16,025
-1,668
| -9% | -$17.1K | ﹤0.01% | 2388 |
|
|
2019
Q1 | $251K | Sell |
17,693
-97
| -0.5% | -$1.28K | ﹤0.01% | 2255 |
|
|
2018
Q4 | $241K | Buy |
17,790
+446
| +3% | +$8.04K | ﹤0.01% | 2188 |
|
|
2018
Q3 | $384K | Sell |
17,344
-756
| -4% | -$15.9K | ﹤0.01% | 2116 |
|
|
2018
Q2 | $297K | Buy |
+18,100
| New | +$318K | ﹤0.01% | 2207 |
|
Other funds holding AMRX
TGA
RCMNY
Prudential Financial's AMRX Position: Q2 2026 in Review
Prudential Financial reduced its Amneal Pharmaceuticals (AMRX) stake by 35% in Q2 2026, selling an estimated $2.48M and leaving 331,168 shares worth $5.73M. The position accounts for 0.01% of the portfolio, ranked #929.
Prudential Financial first reported a position in AMRX in Q2 2018 and has held it in 33 quarters since. The position peaked at $11.5M in Q1 2025. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.
- Prudential Financial held 331,168 shares of Amneal Pharmaceuticals worth $5.73M as of Q2 2026.
- Prudential Financial sold 180,789 Amneal Pharmaceuticals shares in Q2 2026, an estimated $2.48M.
- Amneal Pharmaceuticals made up 0.01% of Prudential Financial's portfolio in Q2 2026, its #929 holding.
- Prudential Financial first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
- Prudential Financial's Amneal Pharmaceuticals position peaked at $11.5M in Q1 2025.
- 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.